Alyeska Investment Group, L.P.

Position in LENZ — LENZ Therapeutics, Inc.

CIK 1453072 CHICAGO, IL

Position in LENZ

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$4,240,979

-$3,174,941 QoQ

Shares Held

463,495

0.0% QoQ

Ownership

1.48%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2024

9 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

Alyeska Investment Group, L.P. holds $1,219,709,732 across 81 Biotechnology names. LENZ ranks #49 (0.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	MRNA	Moderna, Inc.	4,051,185	$205,800,198
2	RVMD	Revolution Medicines, Inc.	1,885,821	$183,396,092
3	JAZZ	Jazz Pharmaceuticals plc	411,015	$77,702,385
4	XENE	Xenon Pharmaceuticals Inc.	1,299,469	$75,564,122
5	PTGX	Protagonist Therapeutics, Inc	593,197	$62,522,963
6	DNLI	Denali Therapeutics Inc.	1,941,123	$37,269,561
7	IONS	Ionis Pharmaceuticals Inc	473,150	$35,528,833
8	TECH	BIO-TECHNE Corp	659,049	$34,441,900

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$4,240,979	463,495	0.0%	Shares	Sole	2026-05-15
2025-12-31	$7,415,920	463,495	+91.4%	Shares	Sole	2026-02-13
2025-09-30	$11,277,623	242,113	+11.5%	Shares	Sole	2025-11-17
2025-06-30	$6,363,582	217,113	+52.8%	Shares	Sole	2025-08-14
2025-03-31	$3,653,725	142,113	0.0%	Shares	Sole	2025-05-15
2024-12-31	$4,102,802	142,113	+16.4%	Shares	Sole	2025-02-14
2024-09-30	$2,898,962	122,113	-62.0%	Shares	Sole	2024-11-14
2024-06-30	$5,562,452	321,715	+61.2%	Shares	Sole	2024-08-14
2024-03-31	$4,457,112	199,602	—	Shares	Sole	2024-05-15
No filing history on record for this holder in this stock.